Vivos (RDGL) Return on Capital Employed Growth (3y) (2014 - 2025)
Vivos (RDGL) Return on Capital Employed Growth (3y) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.38 Bn | 176.08 Bn | 6.27 Bn | -1,679.00 |
| 2 | Stryker | 129.56 Bn | 126.68 Bn | 3.81 Bn | 214.00 |
| 3 | Medtronic | 109.00 Bn | 99.78 Bn | 6.41 Bn | 145.00 |
| 4 | Boston Scientific | 68.59 Bn | 67.13 Bn | 3.61 Bn | 355.00 |
| 5 | Edwards Lifesciences | 47.58 Bn | 43.90 Bn | 1.29 Bn | -846.00 |
| 6 | Dexcom | 28.65 Bn | 27.53 Bn | 750.30 Mn | 1,318.00 |
| 7 | GE HealthCare Technologies | 28.55 Bn | 26.27 Bn | 1.98 Bn | -247.00 |
| 8 | Smith & Nephew | 27.05 Bn | 26.48 Bn | - | - |
| 9 | Koninklijke Philips | 25.59 Bn | 22.46 Bn | 2.07 Bn | - |
| 10 | Vivos | 27.57 Mn | 26.01 Mn | -3,105.00 | -2,230.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2,230.00 |
| Sep 30, 2025 | 3,065.00 |
| Jun 30, 2025 | 9,277.00 |
| Mar 31, 2025 | 10,855.00 |
| Dec 31, 2024 | -797.00 |
| Sep 30, 2024 | -2,811.00 |
| Jun 30, 2024 | -5,163.00 |
| Mar 31, 2024 | -14,401.00 |
| Dec 31, 2023 | -37,285.00 |
| Sep 30, 2023 | -25,638.00 |
| Dec 31, 2022 | -23,368.00 |
| Sep 30, 2022 | -35,873.00 |
| Jun 30, 2022 | -38,032.00 |
| Mar 31, 2022 | -44,523.00 |
| Dec 31, 2021 | -41,320.00 |
| Sep 30, 2021 | -17,391.00 |
| Jun 30, 2021 | -16,324.00 |
| Mar 31, 2021 | -12,560.00 |
| Dec 31, 2020 | 10,343.00 |
| Sep 30, 2020 | 3,980.00 |